Interferon and Ribavirin - The Body
Links shared publicly online about this topic.
- 367total visits
Interferon and Ribavirin - The Body
View full resource at thebody.com
Tags: Liver Condition, Hepatitis, Hepatitis C Medication, HIV, AIDS, STD, Rebetol
Most Recently Shared on April 13, 2011 at 9:01 pm By:
Interferon and Ribavirin http://bit.ly/eccsBY #hiv #aids #hepatitis #hepc #hcv
HCV New Drug Research: EASL-Abbott Presents Positive Results from Interferon-Free Phase 2 "Co-Pilot" Study for the Treatment of Hepatitis C-ABT-450/r, plus ABT-333 and ribavirin
hepatitiscnewdrugs.blogspot.com — “HCV New Drug Research: EASL-Abbott Presents Positive Results from Interferon-Free Phase 2 "Co-Pilot" Study for the Treatment of Hepatitis C-ABT-450/r, plus ABT-333 and ribavirin” View full resource at hepatitiscnewdrugs.blogspot.com
Most Recently Shared on April 19, 2012 at 4:12 pm By:
Tina Banwart - HepatitisCNewDrugs Health Blog
EASL-Abbott Presents Positive Results from Interferon-Free Phase 2 "Co-Pilot" Study for the… http://t.co/es8fhWgM
Infectious Disease News - Durability of sustained response shown in paediatric patients with chronic hepatitis C who were treated with interferon alfa-2b plus ribavirin |3975179
mdlinx.com — “Infectious Disease Medical Article: Durability of sustained response shown in paediatric patients with chronic hepatitis C who were treated with interferon alfa-2b plus ribavirin” View full resource at mdlinx.com
Most Recently Shared on March 16, 2012 at 11:32 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Durability of sustained response shown in paediatric patients with chronic hepatitis C who were treated with... http://t.co/E2vZtfPw #ID
HCV New Drug Research: The effect of pegylated interferon-alpha2b and ribavirin combination therapy for chronic hepatitis C infection in elderly patients
hepatitiscnewdrugs.blogspot.com — “HCV New Drug Research: The effect of pegylated interferon-alpha2b and ribavirin combination therapy for chronic hepatitis C infection in elderly patients” View full resource at hepatitiscnewdrugs.blogspot.com
Most Recently Shared on March 10, 2012 at 1:54 pm By:
Tina Banwart - HepatitisCNewDrugs Health Blog
The effect of pegylated interferon-alpha2b and ribavirin combination therapy for chronic… http://t.co/zGPKmbhY
Vertex Announces 12-Week On-Treatment Data and SVR4 From Phase 2 Study of Interferon-Free (All-Oral) Treatment Regimen of INCIVEK®, VX-222 and Ribavirin in People with Genotype 1 Hepatitis C | EON: Enhanced Online News
eon.businesswire.com — “Vertex Announces 12-Week On-Treatment Data and SVR4 From Phase 2 Study of Interferon-Free (All-Oral) Treatment Regimen of INCIVEK®, VX-222 and Rib” View full resource at eon.businesswire.com
Most Recently Shared on February 23, 2012 at 1:46 pm By:
John Carroll Health Communicator
Interesting that Vertex is highlighting it can get to an NDA as early as late '14 on its new hep C combo. It's a race. http://t.co/9CF6FtCS
Insight into role of cytokines in autoimmune diseases
news-medical.net — “Cytokines, a varied group of signaling chemicals in the body, have been described as the software that runs the immune system, but when that software malfunctions, dysregulation of the immune system can result in debilitating autoimmune diseases such as lupus, arthritis, and diabetes. Leading experts in the field of cytokine research present their most up-to-date findings and unique perspectives on the role of cytokines in autoimmune diseases in a special issue of Journal of Interferon & Cyt” View full resource at news-medical.net
Most Recently Shared on October 28, 2011 at 6:02 am By:
Arthritis News: Insight into role of cytokines in autoimmune diseases: Cytokines, a varied group of signaling ch... http://t.co/4Dyhzz6X
Gastroenterology Article | Dynamics of regulatory T cells and plasmacytoid dendritic cells as immune markers for virological response in pegylated interferon-α and ribavirin therapy for chronic hepatitis C patients
mdlinx.com — “Dynamics of regulatory T cells and plasmacytoid dendritic cells as immune markers for virological response in pegylated interferon-α and ribavirin therapy for chronic hepatitis C patients” View full resource at mdlinx.com
Most Recently Shared on October 7, 2011 at 11:10 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Dynamics of regulatory T cells and plasmacytoid dendritic cells as immune markers for virological response i... http://t.co/8oEuSp3Y #GI
Alcohol impairs the body's ability to fight off viral infection, study finds
sciencedaily.com — “Alcohol can worsen the effects of disease. New research shows that alcohol modulates the anti-viral and inflammatory functions of monocytes. Prolonged alcohol consumption has a double negative effect of reducing the anti-viral effect of Type 1 interferon (IFN) whilst increasing inflammation via the pro-inflammatory cytokine TNF±. Consequently this may impair host response to single-stranded virus infection like hepatitis C.” View full resource at sciencedaily.com
Most Recently Shared on September 30, 2011 at 1:30 pm By:
Dr. Adam Tetuan Chiropractor, Doctor, and CAM
Alcohol impairs the body's ability to fight off viral infection, study finds. #alcohol #infection #viral #health #in http://t.co/BVwbwUkL
FDA Approve Telaprevir (Incivek) to Treat Hepatitis C - The Body
thebody.com — “On 23 May 2011, the FDA approved telaprevir (Incivek) to be used in combination with peginterferon alfa and ribavirin to treat hepatitis C genotype 1. ...” View full resource at thebody.com
Most Recently Shared on September 19, 2011 at 12:00 pm By:
FDA Approve Telaprevir (Incivek) to Treat Hepatitis C http://t.co/86IxiIpA #hcv
new hep c treatment - Forum on Hepatitis and HIV Coinfection
thebody.com — “Telaprevir is a new HCV protease inhibitor. It is a very potent drug that is effective against genotype 1 infection. If you are not responding well to pegylated interferon and ribavirin, you may...” View full resource at thebody.com
Most Recently Shared on September 7, 2011 at 6:01 pm By:
Ask the HIV/AIDS Experts: "Did Not Respond Well to Interferon and Ribavirin: Should I Try Telaprevir to Treat My HCV?" http://t.co/dPHQLy4
Gilead Amends Study Design for Ongoing Hepatitis C Clinical Trials That Include GS 9190, Pegylated Interferon and Ribavirin, and Another Direct-Acting Antiviral Agent - Drugs.com MedNews
drugs.com — “Change Does Not Affect Ongoing All Oral Clinical Trials Evaluating Multiple Direct-Acting Antivirals in Combination Sep 4, 2011 - Gilead Sciences, Inc. (Nasdaq” View full resource at drugs.com
Most Recently Shared on September 6, 2011 at 3:07 pm By:
Drugs and Devices OW OW Health
Gilead Amends Study Design for Ongoing Hepatitis C Clinical Trials That Include GS 9190, Pegylated Interfe... http://t.co/jzjbfAb #drug
Gilead to amend design of ongoing clinical trials against chronic hepatitis C
news-medical.net — “Gilead Sciences, Inc. today announced that, in consultation with the U.S. Food and Drug Administration (FDA), the company will amend the design of ongoing clinical trials to discontinue dosing of GS 9190 in hepatitis C-infected patients who are receiving that compound in combination with pegylated interferon and ribavirin, and another direct-acting antiviral agent.” View full resource at news-medical.net
Most Recently Shared on September 5, 2011 at 9:49 am By:
Gilead to amend design of ongoing clinical trials against chronic hepatitis C: Gilead Sciences, Inc. today annou... http://t.co/XIh4nlZ
New genetic markers promising as a guide to HCV therapy | Gastroenterology Update
gastroenterologyupdate.com.au — “Two newly discovered genes have considerable promise as predictors of patients’ response to pegylated interferon and ribavirin.” View full resource at gastroenterologyupdate.com.au
Most Recently Shared on August 31, 2011 at 6:29 am By:
Gastroenterology Upd Gastroenterology and Medical Publisher
New genetic markers promising as a guide to HCV therapy http://t.co/ciXeHw4 #gastroenterology
Cracking the interferon code
medicalxpress.com — “(Medical Xpress) -- Interferons, protective chemicals produced by most cells in the body, live up to their name, hampering cancer and viral infections. It takes many different kinds of interferon molecules to get the job done, with each one activating a particular component of the body’s defense ...” View full resource at medicalxpress.com
Most Recently Shared on August 24, 2011 at 1:30 pm By:
PhysOrg Health News Health News
Cracking the interferon code http://t.co/3GHyfAf
Family Medicine Article | Hepatitis C
mdlinx.com — “Efficacy of pegylated interferon plus ribavirin combination therapy for hepatitis C patients with normal ALT levels: a matched case-control study” View full resource at mdlinx.com
Most Recently Shared on August 22, 2011 at 5:52 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Efficacy of pegylated interferon plus ribavirin combination therapy for hepatitis C patients with n... http://t.co/4NW6yXt #FamPractice
Gastroenterology Article | Hepatitis C
mdlinx.com — “Efficacy of pegylated interferon plus ribavirin combination therapy for hepatitis C patients with normal ALT levels: a matched case-control study” View full resource at mdlinx.com
Most Recently Shared on August 22, 2011 at 11:25 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Efficacy of pegylated interferon plus ribavirin combination therapy for hepatitis C patients with normal ALT... http://t.co/Oyu6sKx #GI
Advertisement
